Four new indicators in the investment and impact fund (IIF) will support primary care teams in reducing carbon emissions from inhalers. Primary care networks (PCNs) are now rewarded for reducing their proportion of non-salbutamol metered dose inhalers prescribed, where clinically appropriate; and prescribing lower carbon salbutamol inhalers.
From April 2022, two more indicators will support regular prescribing of inhaled corticosteroid for asthma patients and reductions in avoidable short acting beta-agonist prescribing.
Dispensaries should work collaboratively with their local PCNs to support patients prescribed a new or different inhaler by checking inhaler technique, checking children have appropriate spacer devices and personalised asthma action plans, and encouraging patients to return their inhalers for disposal.
‘Green’ general practice was covered in the 2021 DDA annual conference.